CL vs LAB
Colgate-Palmolive Company (CL) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported CL revenue for 2025-12-31 was $20.38B. Net income was $2.13B. Revenue was up 1.4% from 2024-12-31 to 2025-12-31. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
CL currently screens at market cap $70.88B and trailing P/E 34.3. LAB currently screens at market cap $317.1M.
Not investment advice. Open the CL and LAB stock pages for the full models.
Not investment advice.